Top Pharmaceutical Products Companies By Revenue

Revenue
RevenueEfficiencyMarket RiskExp Return
1MRNA Moderna
6.85 B
(0.38)
 3.19 
(1.20)
2TLX Telix Pharmaceuticals Limited
645.68 M
(0.09)
 1.98 
(0.18)
3LSBPW LakeShore Biopharma Co,
573.42 M
(0.03)
 11.64 
(0.35)
4DNLI Denali Therapeutics
330.53 M
 0.01 
 3.45 
 0.04 
5MRVI Maravai Lifesciences Holdings
288.94 M
(0.12)
 6.04 
(0.75)
6DVAX Dynavax Technologies
232.28 M
 0.05 
 2.47 
 0.12 
7ME 23Andme Holding Co
219.64 M
(0.14)
 6.56 
(0.90)
8MNKD MannKind Corp
198.96 M
 0.19 
 2.21 
 0.41 
9VCEL Vericel Corp Ord
197.52 M
 0.09 
 3.06 
 0.28 
10MIRM Mirum Pharmaceuticals
186.37 M
 0.05 
 2.51 
 0.13 
11CAMP CAMP4 THERAPEUTICS PORATION
186.23 M
(0.23)
 8.57 
(1.93)
12VALN Valneva SE ADR
153.71 M
(0.31)
 2.47 
(0.76)
13MCRB Seres Therapeutics
126.33 M
 0.01 
 6.24 
 0.08 
14FBIOP Fortress Biotech Pref
68.79 M
(0.13)
 2.84 
(0.36)
15MEIP MEI Pharma
65.3 M
(0.06)
 2.62 
(0.15)
16MGNX MacroGenics
58.75 M
 0.00 
 4.24 
(0.01)
17MTEM Molecular Templates
57.31 M
 0.02 
 28.20 
 0.70 
18DTIL Precision BioSciences
48.73 M
(0.16)
 2.69 
(0.43)
19SNYR SYNERGY CHC P
46.63 M
 0.28 
 257.65 
 73.33 
20MRUS Merus BV
43.95 M
(0.16)
 2.05 
(0.33)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates. Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.